<DOC>
	<DOCNO>NCT01916967</DOCNO>
	<brief_summary>This study evaluate efficacy safety desloratadine ( MK-4117 ) Japanese participant chronic urticaria . The primary hypothesis efficacy desloratadine 10 mg 5 mg superior placebo base change Baseline sum score pruritus/itch rash assess Investigator Week 2 .</brief_summary>
	<brief_title>An Efficacy Safety Study Desloratadine ( MK-4117 ) Japanese Participants With Chronic Urticaria ( MK-4117-201 )</brief_title>
	<detailed_description />
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Histamine</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<mesh_term>Histamine H1 Antagonists , Non-Sedating</mesh_term>
	<mesh_term>Histamine H1 Antagonists</mesh_term>
	<criteria>Chronic urticaria [ rash ( erythema , wheal ) 1 month without know cause ] Outpatient Stimulationinduced urticaria [ physical urticaria ( e.g . cold , solar , heat urticaria ) , cholinergic urticaria , contact urticaria ) ] Hypersensitivity antihistamine ingredient study drug</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Urticaria</keyword>
	<keyword>Skin Diseases , Vascular</keyword>
	<keyword>Skin Diseases</keyword>
	<keyword>Hypersensitivity , Immediate</keyword>
	<keyword>Hypersensitivity</keyword>
	<keyword>Immune System Diseases</keyword>
	<keyword>Cholinergic Antagonists</keyword>
	<keyword>Cholinergic Agents</keyword>
	<keyword>Neurotransmitter Agents</keyword>
	<keyword>Histamine H1 Antagonists , Non-Sedating</keyword>
	<keyword>Histamine H1 Antagonists</keyword>
	<keyword>Histamine Antagonists</keyword>
	<keyword>Histamine Agents</keyword>
</DOC>